ARCHIVES

Conference Level For NCI Is 5.4% Over FY 1990

This article is from The Cancer Letter archive.

Vol. 16 No. 42 | November 2, 1990

Download PDF Visit The Full Archive

Related Articles

NCI Programs: Coleman To Lead NCI’s New Radiation Oncology Program

February 5, 1999

FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer

January 28, 2005

Final Issue Of Decade; Office Closed, But Not Phone Or Fax

December 15, 1989

Professional Societies: ASCO opposes FDA On Stem Cell Transplant Regs

May 16, 1997

NCI Announces Designation Of Comprehensive Center

July 20, 1990

In Brief: Arkansas, Iowa Appoint Center Directors; Broder Moves To Gene Sequencing Venture

August 14, 1998